Moxalactam in Treatment of Recurrent Escherichia Coli Meningitis and Ventriculitis in an Infant with Agammaglobulinemia

Abstract

French

Keywords

moxalactam E. Coli meningitis ventriculitis agammaglobulinemia

Get full access to this article

View all access options for this article.

References

Kaiser

, McGee

. Aminoglycoside therapy of gram-negative bacillary meningitis. N Engl J Med 1975; 293: 1215.

Schaad

, McCracken

Jr Pharmacology of LY 127935 (LY) in neonates: relevance to use in neonatal coliform meningitis. Ped Res 1980; 14: 564.

Flounioy

, Perryman

. LY 127935, a new beta-lactam antibiotic, versus Proteus, Klebsiella, Serratia, and Pseudomonas. Antimicrob Agents Chemother 1979; 16: 641.

Neu

, et

. Antibacterial activity of a new 1-OXA cephalosporin compared with that of other β-lactam compounds. Antimicrob Agents Chemother 1979; 16: 141, 528(erratum).

Hall

, et

. Comparative activities of the oxa-β-lactam LY 127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiple, resistant gram-negative bacilli. Antimicrob Agents Chemother 1980; 17: 273.

Cordera

, Pekarek

. Treatment of experimental Haemophilus influenzae type B meningitis with 1-oxa-β-lactam (LY 127935). Antimicrob Agents Chemother 1980; 17: 258.